Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Israel

European Research Council grant · Finished

IntraopRealtimeTumor A Real-time imaging and classification system for low-grade glioma detection during brain surgery

Coordinator
Tel Aviv University, Israel
Runs
1 October 2022 to 30 September 2024
Status
Finished
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101066138

What the project is doing

In the project's own words, from its summary on CORDIS.

Brain tumors remain one of the most incurable illnesses we know; patients have poor prognosis and less than a decade of life expectancy. The oncologist’s toolkit is rather limited as chemotherapy agents have limited access to the brain due to the blood brain barrier selective permeability and radiotherapy results in extensive damage to tissue well beyond the targeted area; leaving surgical removal of the tumor as the most effective approach.

It has now become clear that the completeness of the surgical removal of the tumor is the most important factor determining recurrency of the illness. As such, tools that enable neurosurgeons to effectively remove the tumor are of fundamental importance in the surgical theater. Recent advances in intraoperative fluorescent labeling of common brain tumors has proven to dramatically improve surgical outcome. Unfortunately, no such labeling or intraoperative aid exists for the highly infiltrative low-grade glioma (LGG), making it the deadliest type.

This PoC project aims to tackle this urgent unmet need and develop an intraoperative, real-time imaging and tissue classification tool for precise on-site identification of LGG tissue. The core technology emanates from the multiphoton ultrafast volumetric imaging we developed (now able to run in real-time) to study the link between neuronal activity and blood flow. Here we harness this unique technology and extended it to perform real-time label-free multimodal acquisition and image processing using the latest deep-learning tools.

Our tool will provide surgeons with the ability to discern, while operating, healthy vs tumor tissue. Together with neurosurgeons, a technological hardware partner and an expert in artificial intelligence, we are positioned to generate the first-of-its kind prototype and to seek its commercialization. Such a tool is expected to become a game changer in brain and other tumor surgeries, improving the life expectancy and quality of many patients and families.

Topics

Who is involved

OrganisationCityCountryRole
Tel Aviv UniversityTel AvivIsraelCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI